Global Cord Blood (NYSE:CO) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued on Wednesday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of NYSE CO remained flat at $1.30 during midday trading on Wednesday. The firm’s 50-day moving average is $1.59 and its two-hundred day moving average is $1.40. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50. The company has a market cap of $158.02 million, a P/E ratio of 2.03 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.